Novel dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them

Details for Australian Patent Application No. 2007232311 (hide)

Owner Mylan Laboratories Ltd

Inventors Gopalan, Balasubramanian; Ishtiyaque, Ahmad; Rasheed, Mohammed; Sreedhara, Swamy Keshavapura Hosamane; Ravi, Dhamjewar

Agent Spruson & Ferguson

Pub. Number AU-B-2007232311

PCT Pub. Number WO2007/113634

Priority 60/801,437 18.05.06 US; 610/CHE/2006 03.04.06 IN

Filing date 30 March 2007

Wipo publication date 11 October 2007

Acceptance publication date 9 August 2012

International Classifications

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4196 - 1,2,4-Triazoles

C07D 207/26 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/32 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/48 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 233/36 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 271/06 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 275/02 Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 277/34 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/113634 Priority application(s): WO2007/113634

16 February 2012 Alteration of Name

  The name of the applicant has been altered to Mylan Laboratories Ltd

9 August 2012 Application Accepted

  Published as AU-B-2007232311

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007232314-Prediction of heterosis and other traits by transcriptome analysis

2007232298-Adhesive laminates and applications thereof